Antoine Yver's Net Worth
$12.3 Million
Who is Antoine Yver?
Antoine Yver has an estimated net worth of $12.3 Million. This is based on reported shares in Centessa Pharmaceuticals plc.
SEC CIK
Antoine Yver's CIK is 0001861878
Past Insider Trading and Trends
2022 was Antoine Yver's most active year for acquiring shares with 2 total transactions. Antoine Yver's most active month to acquire stocks was the month of January. 2022 was Antoine Yver's most active year for disposing of shares, totalling 14 transactions. Antoine Yver's most active month to dispose stocks was the month of April. 2021 saw Antoine Yver paying a total of $0.00 for 833,897 shares, this is the most they've acquired in one year. In 2022 Antoine Yver cashed out on 197,738 shares for a total of $930,160.39, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Centessa Pharmaceuticals plc (CNTA) Snapshot price: $14.3
EVP & Chairman Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.82% | -6.50K |
$4.45 | -$28,949.05 | 783.07K |
Jun 1
| |||
Form 4
| -0.85% | -6.80K |
$4.42 | -$30,083.20 | 789.57K |
May 1
| |||
Form 4
| -1.28% | -10.31K |
$3.76 | -$38,828.20 | 796.37K |
Mar 31 - Apr 3
| |||
Form 4
| -0.86% | -7.00K |
$3.42 | -$23,970.10 | 806.68K |
Scheduled
|
Mar 1
| ||
Form 4
| +9.34% | 69.5K |
$3.79 | -$29,200.71 | 813.68K |
Scheduled
|
Feb 1
| ||
Form 4
| -0.98% | -7.73K |
$4.25 | -$32,861.00 | 782.02K |
Sep 30
| |||
Form 4
| -1.21% | -9.24K |
$3.16 | -$29,166.82 | 751.91K |
Scheduled
|
Dec 31 - Jan 4
| ||
Form 4
| -1.22% | -9.40K |
$3.91 | -$36,743.66 | 761.15K |
Scheduled
|
Dec 1
| ||
Form 4/A
| -1.20% | -9.50K |
$3.91 | -$37,107.95 | 780.25K |
Scheduled
|
Oct 3
| ||
Form 4
| -1.25% | -9.70K |
$4.03 | -$39,055.11 | 765.06K |
Scheduled
|
Nov 1
| ||
Form 4
| -1.90% | -14.99K |
$3.94 | -$59,091.09 | 774.76K |
Sep 30 - Oct 3
| |||
Form 4
| -1.30% | -10.42K |
$4.41 | -$45,987.32 | 789.75K |
Scheduled
|
Sep 1
| ||
Form 4
| -1.29% | -10.42K |
$4.45 | -$46,405.28 | 800.17K |
Scheduled
|
Aug 1
| ||
Form 4
| -2.41% | -20.00K |
$4.87 | -$97,312.00 | 810.6K |
Scheduled
|
Jul 18
| ||
Form 4
| +12.29% | 90.9K |
$5.03 | -$45,796.66 | 830.6K |
Jul 1
| |||
Form 4
| -1.23% | -9.20K |
$4.68 | -$43,035.76 | 739.7K |
Jun 17
| |||
Form 4
| -10.19% | -85.00K |
$5.17 | -$439,733.76 | 748.9K |
May 17 - May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
∞
| 833.9K |
—
|
—
| 833.9K |
May 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||